Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities research analysts at B. Riley issued their Q1 2024 earnings per share (EPS) estimates for shares of Ovid Therapeutics in a research note issued to investors on Monday, April 29th. B. Riley analyst K. Patel expects that the company will earn ($0.26) per share for the […]
BeyondSpring (NASDAQ:BYSI – Get Free Report) and Ovid Therapeutics (NASDAQ:OVID – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Institutional & Insider Ownership 40.3% of BeyondSpring shares […]
BeyondSpring (NASDAQ:BYSI – Get Free Report) and Ovid Therapeutics (NASDAQ:OVID – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Risk & Volatility BeyondSpring has a beta of […]